chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Pain in extremity
Clinical narrative: On the morning of 01/10/22 the patient experienced rapid heart rate, mild chest pain, and mild shortness of breath, in addition to a sore arm, fatigue, and mild headaches. On 01/11/22 the patient still had chest tightness, but all other symptoms had subsided. The chest tightness lasted through 01/13/22, with the patient experiencing no further side effects on or after 01/14/22. No treatment was administered and patient appears normal, but no tests have been performed to determine any long-term effects.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Intermittent Palpitations ongoing
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chest pain, Induration, Injection site pain, Pain in extremity
Clinical narrative: injection site pain, full arm pain with swelling and more intense pain in the arm pit and upper chest on left side. Forearm is hard and warm to the touch and also has pain with pain to touch.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Skin warm, Tenderness
Clinical narrative: injection site pain, full arm pain with swelling and more intense pain in the arm pit and upper chest on left side. Forearm is hard and warm to the touch and also has pain with pain to touch.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Gastrooesophageal reflux disease, Headache, Pyrexia
Clinical narrative: Day 1 post vaccine: Headache, fatigue, rounds of vomiting, fever, stomach pain, acid reflux Day 2 post vaccine: Fever, fatigue
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Day 1 post vaccine: Headache, fatigue, rounds of vomiting, fever, stomach pain, acid reflux Day 2 post vaccine: Fever, fatigue
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Computerised tomogram, Dysphagia, Eyelid ptosis, Headache
Clinical narrative: Left eye droop (2hours) Unable to swallow or talk (30seconds intermediate for 4 hours)  Both arms numb (2 days)  Severe headache (14 days )
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Laboratory test
Clinical narrative: Left eye droop (2hours) Unable to swallow or talk (30seconds intermediate for 4 hours)  Both arms numb (2 days)  Severe headache (14 days )
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: My heart start giving me hard beating and shorts of breath for about a month now from the next week of vaccination I start have symptoms of my heart want to stop some time and some time working fast like going to get out of my chest I?m healthy I never have problems with my heart
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypoaesthesia, Injection site hypoaesthesia, Injection site nodule, Injection site paraesthesia
Clinical narrative: Vaccine administration error: Janssen COVID19 vaccine administered as second dose, only 13 days after initial dose of Pfizer COVID19 vaccine.  Patient developed tingling and numbness approx. 15 minutes following vaccine administration -- starting at the injection site and spreading to upper back, neck, right arm, and right flank -- and persisting approx. 12 hours.  Patient developed nodule 12mm nodule at injection site approx. 1 week post injection and persisting approx. 3 weeks.  Patient later contracted SARS-COV-2 with a moderate disease course.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Product administration error, SARS-CoV-2 test positive
Clinical narrative: Vaccine administration error: Janssen COVID19 vaccine administered as second dose, only 13 days after initial dose of Pfizer COVID19 vaccine.  Patient developed tingling and numbness approx. 15 minutes following vaccine administration -- starting at the injection site and spreading to upper back, neck, right arm, and right flank -- and persisting approx. 12 hours.  Patient developed nodule 12mm nodule at injection site approx. 1 week post injection and persisting approx. 3 weeks.  Patient later contracted SARS-COV-2 with a moderate disease course.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Hyperglycaemia, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 4/17/21 (lot EW0164), 5/8/21 (lot EW0182), and 12/16/21 (lot FD0810). From 1/13/22 to 1/15/22, patent was admitted to our inpatient med/surg unit for uncontrolled type 2 diabetes with hyperglycemia and COVID-19 infection with possible superimposed bacterial pneumonia (relatively asymptomatic during this hospitalization). On 1/16/22, patient was re-admitted to the hospital with acute respiratory failure with hypoxia and pneumonia due to COVID-19 virus. As of today (1/17/22), patient is still admitted in the med/surg unit.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: Patient received Pfizer COVID vaccine on 4/17/21 (lot EW0164), 5/8/21 (lot EW0182), and 12/16/21 (lot FD0810). From 1/13/22 to 1/15/22, patent was admitted to our inpatient med/surg unit for uncontrolled type 2 diabetes with hyperglycemia and COVID-19 infection with possible superimposed bacterial pneumonia (relatively asymptomatic during this hospitalization). On 1/16/22, patient was re-admitted to the hospital with acute respiratory failure with hypoxia and pneumonia due to COVID-19 virus. As of today (1/17/22), patient is still admitted in the med/surg unit.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Loss of consciousness, Pallor
Clinical narrative: Patient passed out,felt down , unconscious ,he was pale, had  pulse.  We  called emergency I kept talking to patient and wake him up till the ambulance arrived.  I called him after few hours to check on him
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Patient given Pfizer Pediatric Covid-19 vaccine WITHOUT DILUTION. No adverse effects observed in-store. Messages left for primary care physician and mother of child to contact the pharmacy. Pfizer Medical Information contacted and error reported to Drug Safety department. At this time, Pfizer had no specific steps to take other than supportive care for any local/systemic effects that may occur. They did not recommend repeating the dose, and the second dose may be administered at the normal interval of 21 days later. Any judgment to NOT give the second dose must be evaluated on a case-by-case basis.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Cerebral haemorrhage, Computerised tomogram head abnormal, Headache, Magnetic resonance imaging head
Clinical narrative: Presentation at ER  on 10/12/21 for severe headache and migraine symptoms after taking a nap. Head CT scan showed brain bleed. Transfer to another hospital 10/13/21 for week long stay to treat subarachnoid hemorrhage.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging neck, Migraine, Subarachnoid haemorrhage
Clinical narrative: Presentation at ER  on 10/12/21 for severe headache and migraine symptoms after taking a nap. Head CT scan showed brain bleed. Transfer to another hospital 10/13/21 for week long stay to treat subarachnoid hemorrhage.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose normal, Cardiac monitoring, Consciousness fluctuating, Dizziness, Feeling cold
Clinical narrative: 10 minutes after patient received Moderna booster dose she began not to feel well while sitting in the pharmacy waiting area.  She told another customer.  The customer came to the pharmacy counter and notified pharmacy staff.  Pharmacist ran out to give aid to the patient.  Patient said she was light headed and then she passed out.  She went in and out of consciousness.  Pharmacist called 911.  Paramedics came 10 minutes later.  While we waited for the paramedics patient continued to go in and out of consciousness and she complained that she was cold.  Her breathing remained normal.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Malaise
Clinical narrative: 10 minutes after patient received Moderna booster dose she began not to feel well while sitting in the pharmacy waiting area.  She told another customer.  The customer came to the pharmacy counter and notified pharmacy staff.  Pharmacist ran out to give aid to the patient.  Patient said she was light headed and then she passed out.  She went in and out of consciousness.  Pharmacist called 911.  Paramedics came 10 minutes later.  While we waited for the paramedics patient continued to go in and out of consciousness and she complained that she was cold.  Her breathing remained normal.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient given Pfizer pediatric COVID-19 vaccine without dilution. No adverse effects observed in-store. Messages left for primary care physician and mother of child to contact the pharmacy. Pfizer was contacted and error reported. At this time, no specific steps advised other than to take supportive care for any local/systemic effects that may occur. They did not recommend repeating the dose. The second dose may be administered at the normal interval of 21 days later. Any judgment to not give the second dose must be evaluated on a case-by-case basis.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Patient states she started experiencing tingling and numbness on the left side of her body about 10 minutes after administration. I advised the patient to remain seating for a few more minutes. She stated it started feeling a little bit better, but was concerned regarding the numbness. I informed the patient that she could go to emergency room or follow up with PCP.  Patient did inform they were going to the ER.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast swelling, Condition aggravated, Dizziness, Headache, Peripheral swelling
Clinical narrative: This was my booster.  Unbearable increase in tinnitus, swollen arm, armpit and left breast.  Headache and dizziness.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Tinnitus
Clinical narrative: This was my booster.  Unbearable increase in tinnitus, swollen arm, armpit and left breast.  Headache and dizziness.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast cyst, Fatigue, Herpes virus infection, Malaise, Pruritus
Clinical narrative: This was my booster.  Unbearable increase in tinnitus, swollen arm, armpit and left breast.  Headache and dizziness.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: This was my booster.  Unbearable increase in tinnitus, swollen arm, armpit and left breast.  Headache and dizziness.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Vomiting
Clinical narrative: Patient received Covid vaccine (Pfizer 5-11 yr) at around 1pm and was waiting for 15 minutes with her father in our waiting area. Father alerted the pharmacist at around 1:10pm that his daughter was dizzy and clammy and that she thought she may vomit, which she immediately did. Pharmacist grabbed a technician and a cold pack and cleaned her up and had her lie down with her feet up for a few minutes and placed the cold pack on her neck. After about 5 minutes she was feeling fine and we had her sit back up in her chair. She waited a total of 30 minutes and said she felt fine and left with her father.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary, Asthenia, Chest X-ray, Computerised tomogram head, Echocardiogram
Clinical narrative: The night of January 7, I began running a very high fever.  I went to the bathroom several times that night, getting weaker each time. Eventually, I fell and later passed out, waking up in the emergency room, and was admitted for several days.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Fall, Full blood count, Loss of consciousness, Procalcitonin
Clinical narrative: The night of January 7, I began running a very high fever.  I went to the bathroom several times that night, getting weaker each time. Eventually, I fell and later passed out, waking up in the emergency room, and was admitted for several days.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Scan myocardial perfusion, Staphylococcus test negative, Troponin
Clinical narrative: The night of January 7, I began running a very high fever.  I went to the bathroom several times that night, getting weaker each time. Eventually, I fell and later passed out, waking up in the emergency room, and was admitted for several days.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle disorder, Muscle spasms, Muscle twitching
Clinical narrative: Two day after getting the J&J COVID shot I started having muscle spasms. First I had them in my right cheek, then the right side of my neck, then my arms, torso (sides), and legs. Within three days I was having muscle spasms all over my body. Some nights I would wake up due to these spasms. Some spasms were actually twitching muscles and others were a weird electric like buzz running through my muscles. As of today 1/17/22 (20 days after being vaccinated) I still have these muscle spasms. Now they are especially bad in my legs.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Thrombosis
Clinical narrative: When I started my menstrual cycle after the Modena booster (please note Dose 1 and Dose 2 were Pfizer) I had extremely heavy menstrual flow with some large clots that continued for several days. I didn't contact the hospital and or my healthcare provider because I saw where this can happen. It is now better as I'm further along in my cycle.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocardial infarction
Clinical narrative: I suffer major heart attack months after the vaccine
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Back pain, COVID-19, Cough
Clinical narrative: I did not have a reaction to the vaccine. I started to develop a scratchy throat, sneezing, and some nasal drainage on 1/10/2022. I had been in contact with a COVID positive friend on 1/8/2022, I did not know they had COVID at the time. I then started to feel lethargic on 1/11/2022. On 1/12/2022, I developed a fever of 101.2, aches and horrible back and neck pain, headache, sore throat, very dizzy, lethargic. On 1/13/2022, I only had a slight fever of 99.9 or lower, still had bad back and neck pain, sore throat, congestion now was very bad in my head, started to develop a slight cough. On 1/14/2022 no fever, congestion is not as bad, still very dizzy and I get winded very easily. I set up a TeleHealth appointment with my physician and I had a PCR test on 1/13/2022 for COVID, and on 1/14/2022 it was confirmed that I was positive for COVID. It is now 1/17/2022, my congestion in my head is getting better, not as dizzy anymore, still get winded pretty easily if I am up moving around too much, I lost most of my taste and smell on 1/16/2022, I can taste sour things, and can smell stronger smells.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Lethargy, Nasopharyngitis
Clinical narrative: I did not have a reaction to the vaccine. I started to develop a scratchy throat, sneezing, and some nasal drainage on 1/10/2022. I had been in contact with a COVID positive friend on 1/8/2022, I did not know they had COVID at the time. I then started to feel lethargic on 1/11/2022. On 1/12/2022, I developed a fever of 101.2, aches and horrible back and neck pain, headache, sore throat, very dizzy, lethargic. On 1/13/2022, I only had a slight fever of 99.9 or lower, still had bad back and neck pain, sore throat, congestion now was very bad in my head, started to develop a slight cough. On 1/14/2022 no fever, congestion is not as bad, still very dizzy and I get winded very easily. I set up a TeleHealth appointment with my physician and I had a PCR test on 1/13/2022 for COVID, and on 1/14/2022 it was confirmed that I was positive for COVID. It is now 1/17/2022, my congestion in my head is getting better, not as dizzy anymore, still get winded pretty easily if I am up moving around too much, I lost most of my taste and smell on 1/16/2022, I can taste sour things, and can smell stronger smells.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I did not have a reaction to the vaccine. I started to develop a scratchy throat, sneezing, and some nasal drainage on 1/10/2022. I had been in contact with a COVID positive friend on 1/8/2022, I did not know they had COVID at the time. I then started to feel lethargic on 1/11/2022. On 1/12/2022, I developed a fever of 101.2, aches and horrible back and neck pain, headache, sore throat, very dizzy, lethargic. On 1/13/2022, I only had a slight fever of 99.9 or lower, still had bad back and neck pain, sore throat, congestion now was very bad in my head, started to develop a slight cough. On 1/14/2022 no fever, congestion is not as bad, still very dizzy and I get winded very easily. I set up a TeleHealth appointment with my physician and I had a PCR test on 1/13/2022 for COVID, and on 1/14/2022 it was confirmed that I was positive for COVID. It is now 1/17/2022, my congestion in my head is getting better, not as dizzy anymore, still get winded pretty easily if I am up moving around too much, I lost most of my taste and smell on 1/16/2022, I can taste sour things, and can smell stronger smells.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Sneezing, Throat irritation
Clinical narrative: I did not have a reaction to the vaccine. I started to develop a scratchy throat, sneezing, and some nasal drainage on 1/10/2022. I had been in contact with a COVID positive friend on 1/8/2022, I did not know they had COVID at the time. I then started to feel lethargic on 1/11/2022. On 1/12/2022, I developed a fever of 101.2, aches and horrible back and neck pain, headache, sore throat, very dizzy, lethargic. On 1/13/2022, I only had a slight fever of 99.9 or lower, still had bad back and neck pain, sore throat, congestion now was very bad in my head, started to develop a slight cough. On 1/14/2022 no fever, congestion is not as bad, still very dizzy and I get winded very easily. I set up a TeleHealth appointment with my physician and I had a PCR test on 1/13/2022 for COVID, and on 1/14/2022 it was confirmed that I was positive for COVID. It is now 1/17/2022, my congestion in my head is getting better, not as dizzy anymore, still get winded pretty easily if I am up moving around too much, I lost most of my taste and smell on 1/16/2022, I can taste sour things, and can smell stronger smells.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: tremors, primarily hands no treatment yet
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: PATIENT WAS GIVEN AN UNDILUTED DOSE (0.2 ML) OF THE PFIZER PEDIATRIC COVID VACCINE. NO ADVERSE REACTIONS WERE REPORTED.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site nodule, Injection site pain, Injection site warmth, Insomnia
Clinical narrative: I received the Covid-19 vaccine on 1/4/22. I have had severe soreness at the infection site since I got the injection. On Thursday evening 1/13/22 a firm quarter sized red nodule appeared on my left upper arm that was hot to touch. Over the next couple of days the spot has spread out with sever redness, itching, and dull pain. Hard to sleep on that arm without severe soreness and very hot to touch. As of 1/17/22 this area is still present and spreading in size.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus
Clinical narrative: I received the Covid-19 vaccine on 1/4/22. I have had severe soreness at the infection site since I got the injection. On Thursday evening 1/13/22 a firm quarter sized red nodule appeared on my left upper arm that was hot to touch. Over the next couple of days the spot has spread out with sever redness, itching, and dull pain. Hard to sleep on that arm without severe soreness and very hot to touch. As of 1/17/22 this area is still present and spreading in size.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: PATIENT WAS GIVEN AN UNDILUTED DOSE (0.2 ML) OF PFIZER PEDIATRIC COVID 19 VACCINE.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Gait disturbance, Headache, Influenza A virus test negative
Clinical narrative: I woke up on 12/31/2021 in so much pain I could barely walk or move.  Every muscle and joint hurt, I walked like I was 90 years old.  My lymph nodes swelled so much I ended up having headaches and migraines.  I went to the chiropractor 3 times in less than a week for pain and headaches.  My arm burned and hurt for at least two weeks.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Lymphadenopathy, Migraine, Movement disorder, Myalgia
Clinical narrative: I woke up on 12/31/2021 in so much pain I could barely walk or move.  Every muscle and joint hurt, I walked like I was 90 years old.  My lymph nodes swelled so much I ended up having headaches and migraines.  I went to the chiropractor 3 times in less than a week for pain and headaches.  My arm burned and hurt for at least two weeks.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, SARS-CoV-2 test negative, Sleep disorder
Clinical narrative: I woke up on 12/31/2021 in so much pain I could barely walk or move.  Every muscle and joint hurt, I walked like I was 90 years old.  My lymph nodes swelled so much I ended up having headaches and migraines.  I went to the chiropractor 3 times in less than a week for pain and headaches.  My arm burned and hurt for at least two weeks.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pain in extremity
Clinical narrative: Immediate and persistent pain in the upper left  arm; can?t raise it to the side without excruciating pain. Difficult to put arm in coat and reach for seat belt. Two months post vaccine it?s not getting any better.  Didn?t report it previously and didn?t pursue  treatment thinking it would get better over time, but it?s not.
Age: 15.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient is about to turn 16 years old presented to the pharmacy to get the COVID-19 booster. A 0.25 ml of Moderna vaccine was administered intramuscularly to the patient. Moderna booster has not been approved for patients under 18 years old. Patient's mother was contacted and reported no adverse reaction happened to the patient and that patient was completely fine. According to our clinical coordinator, no repeat of covid-19 booster is required for this patient at this time. Patient's caregiver will also reach out to the patient's PCP and let him/her know what happened.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Patient received booster and next day noticed chest discomfort and pressure.  I told her I would check with her 3 or 4 days later to see if she still has same symptoms.  She informed us yes, and believes the booster caused this.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient was given undiluted dose (0.2 ml) of Pfizer pediatric Covid vaccine (PEDS), mother and doctor were notified. At the time of notification no adverse effects were observed. Patient's mother was instructed to call if any adverse events occurred.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Blood culture negative, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram abnormal
Clinical narrative: Hospitalized (1.10.22);  COVID-19 positive (1.11.22);  Fully vaccinated PLUS booster DATE OF ADMISSION:  01/10/2022 DATE OF DISCHARGE:  01/13/2022 DISCHARGE DIAGNOSES 1. COVID-19 pneumonia with acute hypoxemic respiratory failure. 2. Acute drop in hemoglobin, lab error. 3. Acute on chronic diarrhea. 4. Episode of ventricular tachycardia, prolonged QTc. 5. Hypokalemia. 6. Multiple myeloma. 7. Papillary carcinoma of the thyroid. 8. Postsurgical hypothyroidism. 9. Anxiety and depression. 10. Gastroesophageal reflux disease HOSPITAL COURSE The patient is a very pleasant 60-year-old female with past medical history as listed above including multiple myeloma and bone marrow transplant x2, who presented initially to Urgent Care secondary to worsening shortness of breath and cough.  She initially developed upper respiratory symptoms, January 1st and with progression of symptoms, she proceeded to Urgent Care where her COVID test was positive.  She was sent to a local Emergency Department for septic workup.  She was hypoxic with ambulation down to 79% on room air in the ER.  Chest x-ray showed bilateral pulmonary opacities consistent with COVID pneumonia.  CT was negative for PE.  Peripheral ground-glass opacities bilaterally were noted.  She was placed on 2 L of oxygen.  Blood cultures were obtained and were negative for bacteria.  She was started on Decadron 6 mg and remdesivir.  Infectious Disease was consulted for possible compassionate use of monoclonal antibodies, although she was outside her window.  Infectious Disease discontinued broad-spectrum antibiotics as they felt there was no bacterial infection component.  The patient had acute on chronic diarrhea.  C diff was negative.  Diarrhea was felt related to her COVID.  This improved with Imodium and Lomotil.  Overall, the patient did very well and was weaned off oxygen at room air.  Pulmonary Rehab was consulted and recommended 2 L of oxygen with ambulation.  Her oxygen level dropped to 87% with ambulation.  We encouraged the patient to stay for at least 1 more dose of remdesivir.  However, the patient was very eager to get home as she has 2 sons at home, 1 with COVID and she is a single mother.  She discharged in stable condition on 01/13/2022.  The patient is encouraged to call our office or proceed to the ED if her symptoms should worsen.  She was sent home with a prescription for Decadron to complete a 10-day course.  Please see report for full discharge instructions.  Chemotherapy will be delayed at least 1 week and followup will be arranged in the Oncology office.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Depression, Diarrhoea, Dyspnoea, Electrocardiogram QT prolonged, Gastrooesophageal reflux disease
Clinical narrative: Hospitalized (1.10.22);  COVID-19 positive (1.11.22);  Fully vaccinated PLUS booster DATE OF ADMISSION:  01/10/2022 DATE OF DISCHARGE:  01/13/2022 DISCHARGE DIAGNOSES 1. COVID-19 pneumonia with acute hypoxemic respiratory failure. 2. Acute drop in hemoglobin, lab error. 3. Acute on chronic diarrhea. 4. Episode of ventricular tachycardia, prolonged QTc. 5. Hypokalemia. 6. Multiple myeloma. 7. Papillary carcinoma of the thyroid. 8. Postsurgical hypothyroidism. 9. Anxiety and depression. 10. Gastroesophageal reflux disease HOSPITAL COURSE The patient is a very pleasant 60-year-old female with past medical history as listed above including multiple myeloma and bone marrow transplant x2, who presented initially to Urgent Care secondary to worsening shortness of breath and cough.  She initially developed upper respiratory symptoms, January 1st and with progression of symptoms, she proceeded to Urgent Care where her COVID test was positive.  She was sent to a local Emergency Department for septic workup.  She was hypoxic with ambulation down to 79% on room air in the ER.  Chest x-ray showed bilateral pulmonary opacities consistent with COVID pneumonia.  CT was negative for PE.  Peripheral ground-glass opacities bilaterally were noted.  She was placed on 2 L of oxygen.  Blood cultures were obtained and were negative for bacteria.  She was started on Decadron 6 mg and remdesivir.  Infectious Disease was consulted for possible compassionate use of monoclonal antibodies, although she was outside her window.  Infectious Disease discontinued broad-spectrum antibiotics as they felt there was no bacterial infection component.  The patient had acute on chronic diarrhea.  C diff was negative.  Diarrhea was felt related to her COVID.  This improved with Imodium and Lomotil.  Overall, the patient did very well and was weaned off oxygen at room air.  Pulmonary Rehab was consulted and recommended 2 L of oxygen with ambulation.  Her oxygen level dropped to 87% with ambulation.  We encouraged the patient to stay for at least 1 more dose of remdesivir.  However, the patient was very eager to get home as she has 2 sons at home, 1 with COVID and she is a single mother.  She discharged in stable condition on 01/13/2022.  The patient is encouraged to call our office or proceed to the ED if her symptoms should worsen.  She was sent home with a prescription for Decadron to complete a 10-day course.  Please see report for full discharge instructions.  Chemotherapy will be delayed at least 1 week and followup will be arranged in the Oncology office.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypokalaemia, Hypoxia, Lung opacity, Papillary thyroid cancer, Plasma cell myeloma
Clinical narrative: Hospitalized (1.10.22);  COVID-19 positive (1.11.22);  Fully vaccinated PLUS booster DATE OF ADMISSION:  01/10/2022 DATE OF DISCHARGE:  01/13/2022 DISCHARGE DIAGNOSES 1. COVID-19 pneumonia with acute hypoxemic respiratory failure. 2. Acute drop in hemoglobin, lab error. 3. Acute on chronic diarrhea. 4. Episode of ventricular tachycardia, prolonged QTc. 5. Hypokalemia. 6. Multiple myeloma. 7. Papillary carcinoma of the thyroid. 8. Postsurgical hypothyroidism. 9. Anxiety and depression. 10. Gastroesophageal reflux disease HOSPITAL COURSE The patient is a very pleasant 60-year-old female with past medical history as listed above including multiple myeloma and bone marrow transplant x2, who presented initially to Urgent Care secondary to worsening shortness of breath and cough.  She initially developed upper respiratory symptoms, January 1st and with progression of symptoms, she proceeded to Urgent Care where her COVID test was positive.  She was sent to a local Emergency Department for septic workup.  She was hypoxic with ambulation down to 79% on room air in the ER.  Chest x-ray showed bilateral pulmonary opacities consistent with COVID pneumonia.  CT was negative for PE.  Peripheral ground-glass opacities bilaterally were noted.  She was placed on 2 L of oxygen.  Blood cultures were obtained and were negative for bacteria.  She was started on Decadron 6 mg and remdesivir.  Infectious Disease was consulted for possible compassionate use of monoclonal antibodies, although she was outside her window.  Infectious Disease discontinued broad-spectrum antibiotics as they felt there was no bacterial infection component.  The patient had acute on chronic diarrhea.  C diff was negative.  Diarrhea was felt related to her COVID.  This improved with Imodium and Lomotil.  Overall, the patient did very well and was weaned off oxygen at room air.  Pulmonary Rehab was consulted and recommended 2 L of oxygen with ambulation.  Her oxygen level dropped to 87% with ambulation.  We encouraged the patient to stay for at least 1 more dose of remdesivir.  However, the patient was very eager to get home as she has 2 sons at home, 1 with COVID and she is a single mother.  She discharged in stable condition on 01/13/2022.  The patient is encouraged to call our office or proceed to the ED if her symptoms should worsen.  She was sent home with a prescription for Decadron to complete a 10-day course.  Please see report for full discharge instructions.  Chemotherapy will be delayed at least 1 week and followup will be arranged in the Oncology office.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Post procedural hypothyroidism, Respiratory symptom, SARS-CoV-2 test positive, Ventricular tachycardia
Clinical narrative: Hospitalized (1.10.22);  COVID-19 positive (1.11.22);  Fully vaccinated PLUS booster DATE OF ADMISSION:  01/10/2022 DATE OF DISCHARGE:  01/13/2022 DISCHARGE DIAGNOSES 1. COVID-19 pneumonia with acute hypoxemic respiratory failure. 2. Acute drop in hemoglobin, lab error. 3. Acute on chronic diarrhea. 4. Episode of ventricular tachycardia, prolonged QTc. 5. Hypokalemia. 6. Multiple myeloma. 7. Papillary carcinoma of the thyroid. 8. Postsurgical hypothyroidism. 9. Anxiety and depression. 10. Gastroesophageal reflux disease HOSPITAL COURSE The patient is a very pleasant 60-year-old female with past medical history as listed above including multiple myeloma and bone marrow transplant x2, who presented initially to Urgent Care secondary to worsening shortness of breath and cough.  She initially developed upper respiratory symptoms, January 1st and with progression of symptoms, she proceeded to Urgent Care where her COVID test was positive.  She was sent to a local Emergency Department for septic workup.  She was hypoxic with ambulation down to 79% on room air in the ER.  Chest x-ray showed bilateral pulmonary opacities consistent with COVID pneumonia.  CT was negative for PE.  Peripheral ground-glass opacities bilaterally were noted.  She was placed on 2 L of oxygen.  Blood cultures were obtained and were negative for bacteria.  She was started on Decadron 6 mg and remdesivir.  Infectious Disease was consulted for possible compassionate use of monoclonal antibodies, although she was outside her window.  Infectious Disease discontinued broad-spectrum antibiotics as they felt there was no bacterial infection component.  The patient had acute on chronic diarrhea.  C diff was negative.  Diarrhea was felt related to her COVID.  This improved with Imodium and Lomotil.  Overall, the patient did very well and was weaned off oxygen at room air.  Pulmonary Rehab was consulted and recommended 2 L of oxygen with ambulation.  Her oxygen level dropped to 87% with ambulation.  We encouraged the patient to stay for at least 1 more dose of remdesivir.  However, the patient was very eager to get home as she has 2 sons at home, 1 with COVID and she is a single mother.  She discharged in stable condition on 01/13/2022.  The patient is encouraged to call our office or proceed to the ED if her symptoms should worsen.  She was sent home with a prescription for Decadron to complete a 10-day course.  Please see report for full discharge instructions.  Chemotherapy will be delayed at least 1 week and followup will be arranged in the Oncology office.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: PATIENT WAS GIVEN UNDILUTED DOSE (0.2ML) OF PFIZER PEDIATRIC COVID 19 VACCINE.  PARENTS WERE CONTACTED BUT NO ADVERSE EVENTS OR REACTIONS WERE OBSERVED.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Asthma, Back pain, COVID-19, Computerised tomogram
Clinical narrative: Hospitalized (1.8.22); COVID-19 positive (1.8.22); fully vaccinated. Admission Date: 1/8/2022, Discharge Date: 01/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Lactic acidosis [E87.2], Hypomagnesemia [E83.42], Acute cystitis without hematuria [N30.00], COVID-19 [U07.1], Emphysematous cystitis [N30.80], Cystitis [N30.90]. HOSPITAL COURSE: Patient is a 56 year old female with recent admission for emphysematous cystitis, HTN, asthma, GERD and IBS who presented to the ED with lower abdominal pain radiating to her back on 1/6-1/7. Patient also c/o nausea, vomiting, urinary frequency, and dysuria. Patient was recently admitted 11/21/21-11/24/21 with similar symptoms and found to have emphysematous cystitis. She had a cystoscopy to r/o enterovesical fistula (ruled out) during that admission. Patient was given antibiotics while inpatient and sent home with 14 days of amoxicillin. Patient completed the 2 week course and developed recurrent symptoms. Patient was found to be COVID positive in the ED. She had been vaccinated, but had not received a booster. Patient continued to improve, unclear exact etiology of patient's emphysematous cholecystitis. Urology was contacted in ED and recommended treatment with Cipro for 4 weeks. Infectious Disease was consulted and it was unclear if she indeed relapsed however was possible, despite improved CT, and her symptoms suggested probable urinary tract infection. Previous urine culture grew E coli and it was possible she could have anaerobes that contribute infection that were not well covered by amoxicillin. Infectious Disease recommended changing antibiotics to Augmentin as this would cover previous identified the coli and provide anaerobic coverage. It was noted emphysematous cystitis is typically treated with 10-14 day course of antibiotics and does not require prolonged course as there was no evidence of upper tract/renal involvement. She clinically improved and was discharged on Augmentin to complete 14 day course.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Culture urine positive, Cystitis, Cystoscopy normal, Dysuria
Clinical narrative: Hospitalized (1.8.22); COVID-19 positive (1.8.22); fully vaccinated. Admission Date: 1/8/2022, Discharge Date: 01/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Lactic acidosis [E87.2], Hypomagnesemia [E83.42], Acute cystitis without hematuria [N30.00], COVID-19 [U07.1], Emphysematous cystitis [N30.80], Cystitis [N30.90]. HOSPITAL COURSE: Patient is a 56 year old female with recent admission for emphysematous cystitis, HTN, asthma, GERD and IBS who presented to the ED with lower abdominal pain radiating to her back on 1/6-1/7. Patient also c/o nausea, vomiting, urinary frequency, and dysuria. Patient was recently admitted 11/21/21-11/24/21 with similar symptoms and found to have emphysematous cystitis. She had a cystoscopy to r/o enterovesical fistula (ruled out) during that admission. Patient was given antibiotics while inpatient and sent home with 14 days of amoxicillin. Patient completed the 2 week course and developed recurrent symptoms. Patient was found to be COVID positive in the ED. She had been vaccinated, but had not received a booster. Patient continued to improve, unclear exact etiology of patient's emphysematous cholecystitis. Urology was contacted in ED and recommended treatment with Cipro for 4 weeks. Infectious Disease was consulted and it was unclear if she indeed relapsed however was possible, despite improved CT, and her symptoms suggested probable urinary tract infection. Previous urine culture grew E coli and it was possible she could have anaerobes that contribute infection that were not well covered by amoxicillin. Infectious Disease recommended changing antibiotics to Augmentin as this would cover previous identified the coli and provide anaerobic coverage. It was noted emphysematous cystitis is typically treated with 10-14 day course of antibiotics and does not require prolonged course as there was no evidence of upper tract/renal involvement. She clinically improved and was discharged on Augmentin to complete 14 day course.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Emphysematous cystitis, Escherichia infection, Escherichia test positive, Gastrooesophageal reflux disease, Hypertension
Clinical narrative: Hospitalized (1.8.22); COVID-19 positive (1.8.22); fully vaccinated. Admission Date: 1/8/2022, Discharge Date: 01/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Lactic acidosis [E87.2], Hypomagnesemia [E83.42], Acute cystitis without hematuria [N30.00], COVID-19 [U07.1], Emphysematous cystitis [N30.80], Cystitis [N30.90]. HOSPITAL COURSE: Patient is a 56 year old female with recent admission for emphysematous cystitis, HTN, asthma, GERD and IBS who presented to the ED with lower abdominal pain radiating to her back on 1/6-1/7. Patient also c/o nausea, vomiting, urinary frequency, and dysuria. Patient was recently admitted 11/21/21-11/24/21 with similar symptoms and found to have emphysematous cystitis. She had a cystoscopy to r/o enterovesical fistula (ruled out) during that admission. Patient was given antibiotics while inpatient and sent home with 14 days of amoxicillin. Patient completed the 2 week course and developed recurrent symptoms. Patient was found to be COVID positive in the ED. She had been vaccinated, but had not received a booster. Patient continued to improve, unclear exact etiology of patient's emphysematous cholecystitis. Urology was contacted in ED and recommended treatment with Cipro for 4 weeks. Infectious Disease was consulted and it was unclear if she indeed relapsed however was possible, despite improved CT, and her symptoms suggested probable urinary tract infection. Previous urine culture grew E coli and it was possible she could have anaerobes that contribute infection that were not well covered by amoxicillin. Infectious Disease recommended changing antibiotics to Augmentin as this would cover previous identified the coli and provide anaerobic coverage. It was noted emphysematous cystitis is typically treated with 10-14 day course of antibiotics and does not require prolonged course as there was no evidence of upper tract/renal involvement. She clinically improved and was discharged on Augmentin to complete 14 day course.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypomagnesaemia, Irritable bowel syndrome, Lactic acidosis, Nausea, Pain
Clinical narrative: Hospitalized (1.8.22); COVID-19 positive (1.8.22); fully vaccinated. Admission Date: 1/8/2022, Discharge Date: 01/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Lactic acidosis [E87.2], Hypomagnesemia [E83.42], Acute cystitis without hematuria [N30.00], COVID-19 [U07.1], Emphysematous cystitis [N30.80], Cystitis [N30.90]. HOSPITAL COURSE: Patient is a 56 year old female with recent admission for emphysematous cystitis, HTN, asthma, GERD and IBS who presented to the ED with lower abdominal pain radiating to her back on 1/6-1/7. Patient also c/o nausea, vomiting, urinary frequency, and dysuria. Patient was recently admitted 11/21/21-11/24/21 with similar symptoms and found to have emphysematous cystitis. She had a cystoscopy to r/o enterovesical fistula (ruled out) during that admission. Patient was given antibiotics while inpatient and sent home with 14 days of amoxicillin. Patient completed the 2 week course and developed recurrent symptoms. Patient was found to be COVID positive in the ED. She had been vaccinated, but had not received a booster. Patient continued to improve, unclear exact etiology of patient's emphysematous cholecystitis. Urology was contacted in ED and recommended treatment with Cipro for 4 weeks. Infectious Disease was consulted and it was unclear if she indeed relapsed however was possible, despite improved CT, and her symptoms suggested probable urinary tract infection. Previous urine culture grew E coli and it was possible she could have anaerobes that contribute infection that were not well covered by amoxicillin. Infectious Disease recommended changing antibiotics to Augmentin as this would cover previous identified the coli and provide anaerobic coverage. It was noted emphysematous cystitis is typically treated with 10-14 day course of antibiotics and does not require prolonged course as there was no evidence of upper tract/renal involvement. She clinically improved and was discharged on Augmentin to complete 14 day course.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria, SARS-CoV-2 test positive, Symptom recurrence, Urinary tract infection, Vomiting
Clinical narrative: Hospitalized (1.8.22); COVID-19 positive (1.8.22); fully vaccinated. Admission Date: 1/8/2022, Discharge Date: 01/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Lactic acidosis [E87.2], Hypomagnesemia [E83.42], Acute cystitis without hematuria [N30.00], COVID-19 [U07.1], Emphysematous cystitis [N30.80], Cystitis [N30.90]. HOSPITAL COURSE: Patient is a 56 year old female with recent admission for emphysematous cystitis, HTN, asthma, GERD and IBS who presented to the ED with lower abdominal pain radiating to her back on 1/6-1/7. Patient also c/o nausea, vomiting, urinary frequency, and dysuria. Patient was recently admitted 11/21/21-11/24/21 with similar symptoms and found to have emphysematous cystitis. She had a cystoscopy to r/o enterovesical fistula (ruled out) during that admission. Patient was given antibiotics while inpatient and sent home with 14 days of amoxicillin. Patient completed the 2 week course and developed recurrent symptoms. Patient was found to be COVID positive in the ED. She had been vaccinated, but had not received a booster. Patient continued to improve, unclear exact etiology of patient's emphysematous cholecystitis. Urology was contacted in ED and recommended treatment with Cipro for 4 weeks. Infectious Disease was consulted and it was unclear if she indeed relapsed however was possible, despite improved CT, and her symptoms suggested probable urinary tract infection. Previous urine culture grew E coli and it was possible she could have anaerobes that contribute infection that were not well covered by amoxicillin. Infectious Disease recommended changing antibiotics to Augmentin as this would cover previous identified the coli and provide anaerobic coverage. It was noted emphysematous cystitis is typically treated with 10-14 day course of antibiotics and does not require prolonged course as there was no evidence of upper tract/renal involvement. She clinically improved and was discharged on Augmentin to complete 14 day course.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: PATIENT WAS GIVEN UNDILUTED DOSE (0.2 ML) OF PFIZER PEDIATRIC COVID 19 VACCINE.  PARENTS WERE CONTACTED AND NOTIFIED.  NO ADVERSE REACTIONS WERE NOTED AT THE TIME.  PARENTS WILL REPORT ANY PROBLEMS.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Magnetic resonance imaging, Pain in extremity, X-ray limb normal
Clinical narrative: Patient had acute deltoid and shoulder pain within 1 day of vaccination.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient's father attended clinic with his son to get his son the booster shot. Patient is 13 y.o. male that received Pfizer 0.2ml vaccine instead of the 0.3ml dose.  Patient's father was notified that his son received the incorrect dose for his booster and received a lower dose than he should have.  The vaccinator missed the patient's age.  Additionally, vaccinator was vaccinating children 5-11 years of age only.  I will inquire and confirm what can be done to correct this incident, so the patient is boosted correctly.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation delayed
Clinical narrative: I have not started my menstrual cycle since receiving my Covid vaccines in December 2021. I am now 17 days late.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Hospitalized (1.10.22);  COVID-19 positive (1.10.22); fully vaccinated. Admission Date: 1/10/2022, Discharge Date: 1/12/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia of both lungs due to infectious organism, unspecified part of lung [J18.9], COVID-19 [U07.1], Pneumonia due to COVID-19 virus [U07.1, J12.82]. HOSPITAL COURSE: Patient is a 71 year old male admitted on 1/10/22 for COVID pneumonia. He was told to go to the ER by his PCP after 6-7 days of worsening symptoms. He presented with chills, fever, fatigue, congestion, cough, shortness of breath, and muscle pain. In the ER he was found to be 88% on room air which improved to 90% on 2 liters of nasal cannula. CRP was elevated at 41.7 on admission and trended down to 21.5. His chest x-ray was consistent with COVID pneumonia. He did receive 1 dose of Rocephin in the ER and 1 dose of dexamethasone 6 mg. Patient was given Albuterol inhaler every 6 hours. Blood glucose was between 200-300 during his stay. He was given Insulin lispro to corrective scale. On his second day of admission (1/11/22) he was weaned off oxygen and was 91% on room air. He was given a second dose of dexamethasone 6 mg and given a one time dose of IV Lasix. Today he feels much improved. He is maintaining >90% on room air, afebrile, and denies significant shortness of breath. He feels comfortable being discharged home today.